Post-finasteride syndrome - a true clinical entity?
Level 5 - mechanism / opinion, no new human data
Narrative review evaluating existing literature, controversies, and mechanisms without systematic review methodology
PubMed 39953145 · doi:10.1038/s41443-025-01025-6
What was done
This narrative review evaluated the clinical literature, proposed mechanisms (including neurobiological alterations and genetic predispositions), and diagnostic controversies regarding post-finasteride syndrome (PFS) in men who took finasteride for androgenetic alopecia or benign prostatic enlargement and reported persistent adverse effects after discontinuation.
What was found
The abstract reports no numerical findings or statistical estimates. It notes contrasting data across the literature regarding whether finasteride causes a distinct cluster of persistent sexual, neuropsychiatric, and physical symptoms after cessation.
Why it matters
It highlights persistent safety concerns and clinical uncertainty surrounding finasteride, underscoring the importance of pre-treatment risk assessment and patient counseling.
Limits
The abstract describes a narrative review without reporting systematic search methods, study selection criteria, sample sizes, or quantitative data synthesis.
Cited by
- supports Some patients experience persistent sexual dysfunction even after discontinuing finasteride treatment for hair loss.